Eye Care in the Netherlands
Eye care registered another year of double-digit current value growth in 2018, due to the strong retail environment and solid market fundamentals. Seasonal sales showed a positive trend, driven mainly by the higher incidence of hay fever and pollen. Moreover, the ageing of Dutch society continued to increase the proportion of the elderly population, which are more likely to suffer from poor vision and eye problems.
Euromonitor International's Eye Care in Netherlands report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Allergy Eye Care, Standard Eye Care.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Eye Care market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
- EYE CARE IN THE NETHERLANDS
- Euromonitor International
- February 2019
- LIST OF CONTENTS AND TABLES
- Strong Growth Is Supported by Solid Market Fundamentals
- Seasonal Demand Is Still Dominant, Whilst Chronic Factors Are on the Rise
- Innovations Focus on Hay Fever, Contact Lenses and All-purpose Products
- Competitive Landscape
- Return To Normalcy After the Major Shake-up in 2012
- Reckitt Benckiser Nederland Leads Thanks To Its Optrex Brand
- Similasan Nederland Wins Back Share After Its Relaunch
- Category Data
- Table 1 Sales of Eye Care by Category: Value 2013-2018
- Table 2 Sales of Eye Care by Category: % Value Growth 2013-2018
- Table 3 Sales of Standard Eye Care by Format: % Value 2013-2018
- Table 4 Sales of Standard Eye Care by Positioning: % Value 2013-2018
- Table 5 NBO Company Shares of Eye Care: % Value 2014-2018
- Table 6 LBN Brand Shares of Eye Care: % Value 2015-2018
- Table 7 Forecast Sales of Eye Care by Category: Value 2018-2023
- Table 8 Forecast Sales of Eye Care by Category: % Value Growth 2018-2023
- Executive Summary
- Moderate Value Growth, Largely Driven by Non-otc Categories
- OTC Sales Are Not (yet) Lifted by the Brighter Macroeconomy
- Pharmaceutical Multinationals Dominate, With Private Label the Main Rival
- Supermarkets Gains Ground, To the Detriment of Chemists/pharmacies
- Modest Value Growth Over the Forecast Period
- OTC Registration and Classification
- Vitamins and Dietary Supplements Registration and Classification
- Self-medication/self-care and Preventive Medicine
- Summary 1 OTC: Switches
- Market Indicators
- Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
- Table 10 Life Expectancy at Birth 2013-2018
- Market Data
- Table 11 Sales of Consumer Health by Category: Value 2013-2018
- Table 12 Sales of Consumer Health by Category: % Value Growth 2013-2018
- Table 13 NBO Company Shares of Consumer Health: % Value 2014-2018
- Table 14 LBN Brand Shares of Consumer Health: % Value 2015-2018
- Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
- Table 16 Distribution of Consumer Health by Format: % Value 2013-2018
- Table 17 Distribution of Consumer Health by Format and Category: % Value 2018
- Table 18 Forecast Sales of Consumer Health by Category: Value 2018-2023
- Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
- Summary 2 Research Sources